COVID-19 Associated Fungal Mucormycosis - Covid D Variant Impacts

Pfizer presented a formal report of 'fungi' increasing symptoms world wide back in 2021 and it was tied to the Delta variant of COVID-19, scientifically known as B.1.617.2. It was first identified in late 2020 in India. Pfizer stated: "Due to the spread of the Delta variant, countries could potentially see an increase in fungal infections—not only in India but worldwide. It is important for health care providers to have greater awareness and to be prepared, especially for high-risk patients. Quicker diagnoses, better treatment methods, and more research needed to control these fungal infections." https://www.pfizer.com/news/articles/the_truth_about_covid_19_and_black_fungus

Science on the Mucormycosis fungi, reveals how important testing is for this very dangerous fungal invasion, and as a Long Covid sufferer it is up to me to advocate for my well being by finding physicians that are aware of what Covid D has done to my auto-immune systems: https://en.wikipedia.org/wiki/Mucormycosis